PL2152306T3 - Szczepionki PRRSV oparte na białkach GP5 - Google Patents

Szczepionki PRRSV oparte na białkach GP5

Info

Publication number
PL2152306T3
PL2152306T3 PL08747143T PL08747143T PL2152306T3 PL 2152306 T3 PL2152306 T3 PL 2152306T3 PL 08747143 T PL08747143 T PL 08747143T PL 08747143 T PL08747143 T PL 08747143T PL 2152306 T3 PL2152306 T3 PL 2152306T3
Authority
PL
Poland
Prior art keywords
vaccins
prrsv
proteins
vaccins based
prrsv vaccins
Prior art date
Application number
PL08747143T
Other languages
English (en)
Inventor
Byong-Kwan Kim
Original Assignee
Mj Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mj Biologics Inc filed Critical Mj Biologics Inc
Publication of PL2152306T3 publication Critical patent/PL2152306T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL08747143T 2007-04-30 2008-04-30 Szczepionki PRRSV oparte na białkach GP5 PL2152306T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91504907P 2007-04-30 2007-04-30
EP08747143.9A EP2152306B1 (en) 2007-04-30 2008-04-30 Prrsv vaccins based on gp5 proteins
PCT/US2008/061962 WO2008134697A2 (en) 2007-04-30 2008-04-30 Prrsv vaccins based on gp5 proteins

Publications (1)

Publication Number Publication Date
PL2152306T3 true PL2152306T3 (pl) 2015-07-31

Family

ID=39926318

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08747143T PL2152306T3 (pl) 2007-04-30 2008-04-30 Szczepionki PRRSV oparte na białkach GP5

Country Status (13)

Country Link
US (3) US8142788B2 (pl)
EP (2) EP2152306B1 (pl)
JP (1) JP2010526086A (pl)
KR (1) KR101673883B1 (pl)
CN (1) CN101578112A (pl)
CA (1) CA2685170C (pl)
DK (1) DK2152306T3 (pl)
ES (1) ES2526406T3 (pl)
HK (1) HK1140969A1 (pl)
MX (1) MX2009011638A (pl)
PL (1) PL2152306T3 (pl)
TW (2) TW201605471A (pl)
WO (1) WO2008134697A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142788B2 (en) * 2007-04-30 2012-03-27 Mj Biologics, Inc. PRRSV GP5 based compositions and methods
US9132185B2 (en) 2010-06-02 2015-09-15 Virginia Tech Intellectual Properties, Inc. Modified live-attenuated vaccines (MLV) created by DNA shuffling against porcine reproductive and respiratory syndrome virus (PRRSV)
KR102126398B1 (ko) * 2011-12-30 2020-06-25 유나이티드 바이오메디칼 인크. 돼지 생식기 호흡기 증후군 (prrs)의 효과적인 제어를 위한 합성 펩티드-기반 마커 백신 및 진단 시스템
CA2872789C (en) * 2012-05-17 2019-09-03 Zoetis Llc Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
CN102796181A (zh) * 2012-06-20 2012-11-28 韩健宝 猪繁殖与呼吸综合征病毒的肽核酸及其应用
MX2016009952A (es) 2014-02-07 2017-01-23 Mj Biologics Inc Proteinas y antigenos del virus de diarrea epidemica porcino (pedv).
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
WO2016130569A1 (en) 2015-02-09 2016-08-18 Mj Biologics, Inc. A composition comprising pedv antigens and methods for making and using the composition
KR20170040305A (ko) * 2014-08-08 2017-04-12 이데미쓰 고산 가부시키가이샤 돼지 번식·호흡 장해 증후군 방제제
AR105482A1 (es) * 2015-06-23 2017-10-11 Merial Inc Vectores virales recombinantes que contienen la proteína menor del virus del síndrome reproductor y respiratorio porcino (prrsv) y sus métodos de elaboración y uso
SI3630977T1 (sl) 2017-06-02 2024-05-31 Ambrx, Inc. Postopki in sestavki za spodbujanje proizvodnje beljakovine, ki vsebuje nenaravno aminokislino
CN115785286B (zh) * 2022-12-05 2023-07-14 北京标驰泽惠生物科技有限公司 一种猪繁殖与呼吸综合征病毒的融合蛋白及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156111A1 (en) * 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
ATE461295T1 (de) * 2005-08-30 2010-04-15 Univ Nebraska Verfahren und zusammensetzungen zur impfung von tieren mit prrsv-antigenen mit verbesserter immunogenität
CA2630648C (en) 2005-11-29 2016-01-19 Iowa State University Research Foundation, Inc. Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
US8142788B2 (en) * 2007-04-30 2012-03-27 Mj Biologics, Inc. PRRSV GP5 based compositions and methods

Also Published As

Publication number Publication date
US20090208520A1 (en) 2009-08-20
CA2685170A1 (en) 2008-11-06
WO2008134697A3 (en) 2009-02-12
US20120141978A1 (en) 2012-06-07
JP2010526086A (ja) 2010-07-29
CA2685170C (en) 2017-03-28
MX2009011638A (es) 2010-03-26
HK1140969A1 (en) 2010-10-29
WO2008134697A2 (en) 2008-11-06
KR101673883B1 (ko) 2016-11-08
ES2526406T3 (es) 2015-01-12
CN101578112A (zh) 2009-11-11
EP2152306A2 (en) 2010-02-17
KR20100017504A (ko) 2010-02-16
TW201605471A (zh) 2016-02-16
US20160256536A1 (en) 2016-09-08
EP2152306B1 (en) 2014-11-26
EP2508203A1 (en) 2012-10-10
US8142788B2 (en) 2012-03-27
DK2152306T3 (en) 2014-12-08
TW200914043A (en) 2009-04-01

Similar Documents

Publication Publication Date Title
HK1140969A1 (en) Prrsv vaccins based on gp5 proteins gp5 prrsv
EP1988922A4 (en) PROTEIN FORMULATIONS
HK1210413A1 (en) Oligosaccharide protein conjugates
EP2157885A4 (en) HEADRESTS GESTÄNGE
EP2046930A4 (en) FORMULATIONS BASED ON RHAMNOLIPIDS
GB0703201D0 (en) Formulations
HUE046149T2 (hu) Fehérje
GB0711656D0 (en) Formulations
GB0605780D0 (en) Formulations
GB0716385D0 (en) Formulations
ZA200908969B (en) Formulations
GB0618697D0 (en) Formulations
GB0711957D0 (en) Formulations
GB0610336D0 (en) Formulations
EP2155792A4 (en) OLIGONUCLEOTIDE CONJUGATE OF PROTEIN G
ZA201000806B (en) Immunogenic streptococcus proteins
GB0809979D0 (en) Formulations
IL196646A0 (en) Stable lyophilized preparation
PL2007419T3 (pl) Szczepionka przeciwko mykoplazmie i PRRSV
GB0810232D0 (en) Formulations
GB0719231D0 (en) Protein
GB0718404D0 (en) Formulations
GB0724357D0 (en) Method for preparing protein conjugates
GB0705179D0 (en) Formulations
GB0720563D0 (en) Protein